Tru-D SmartUVC deployed at Frye Regional

In a recent press release, Frye Regional Medical Center, a Duke LifePoint hospital,  added Tru-D SmartUVC to its checklist of disinfection routines aimed at ensuring patients have the highest quality, safest care possible.

Editor's Note: This perss release originally appeared on Tru-D's website. 

"The acquisition of this technology is simply another way that we're working to safeguard the well-being of every single patient who walks through our doors and protect the integrity of our health care environment," said Gar Atchison, CEO of Frye Regional Medical Center. "Tru-D is the only UV disinfection system on the market that has undergone a randomized clinical trial conducted by Duke and funded by the CDC to demonstrate the effectiveness of the technology. In fact, since the study's completion, Duke has purchased 11 Tru-D machines for use at their facilities."

Tru-D, which works by generating UV light energy that modifies the DNA or RNA structure of an infectious cell, is the only portable UV disinfection system on the market with Sensor360 technology. The device's patented technology calculates the amount of UVC energy needed to disinfect an entire room while taking into account room variables – such as size, geometry, surface reflectivity and the amount and location of equipment in the room – and delivers a lethal dose from a single location, effectively eliminating lingering pathogens in the space. This technology, coupled with Tru-D's high-efficiency germicidal lamps, kill deadly germs such as Ebola, methicillin-resistant staphylococcus aureus (MRSA), Clostridium difficile (C. diff), Middle East Respiratory Syndrome (MERS), Norovirus and Enterovirus D68.

Click here to continue >>

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Content

Featured Webinars

Featured Whitepapers